Articles | EuroIntervention

10.4244/EIJV9I6A125 • Oct 25, 2013

Mislabelled table entries in ADVISE Registry by Petraco and colleagues

Johnson NP, Kirkeeide R, Gould K

free

10.4244/EIJV9I6A126 • Oct 25, 2013

Renal denervation for resistant hypertension and new frontiers in interventional medicine: are we forgetting the patient?

Hinterbuchner L

free

10.4244/EIJV9I5A87 • Sep 27, 2013

A sense of “déjà vu”?

Serruys PW

free

10.4244/EIJV9I5A88 • Sep 27, 2013

What is microRNA and should interventionalists be aware of it?

Zhang C

free

10.4244/EIJV9I5A90 • Sep 27, 2013

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y, Zhong S-L

free

10.4244/EIJV9I5A91 • Sep 27, 2013

Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique

Nijhoff F, Agostoni P, Samim M, Ramjankhan F, Kluin J, Doevendans P, Stella P

free

10.4244/EIJV9I5A92 • Sep 27, 2013

Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Schwalm T, Carlsson J, Meissner A, Lagerqvist B, James S

free

10.4244/EIJV9I5A93 • Sep 27, 2013

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S

free

10.4244/EIJV9I5A94 • Sep 27, 2013

A new methodology for accurate 3-dimensional coronary artery reconstruction using routine intravascular ultrasound and angiographic data: implications for widespread assessment of endothelial shear stress in humans

Bourantas C, Papafaklis M, Athanasiou L, Kalatzis F, Naka K, Siogkas P, Takahashi S, Saito S, Fotiadis D, Feldman C, Stone P, Michalis L

free

10.4244/EIJV9I5A95 • Sep 27, 2013

First-in-human experience using the Volcano VIBE-RX vascular imaging balloon catheter system (Volcano IVUS-guided Balloon Evaluation - New Zealand: VIBE-NZ Study)

Watson T, El-Jack S, Stewart J, Ormiston J

free

10.4244/EIJV9I5A96 • Sep 27, 2013

Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography

Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S

free

10.4244/EIJV9I5A97 • Sep 27, 2013

No indication for an unexpected high rate of coronary artery aneurysms after angioplasty with drug-coated balloons

Kleber F-X, Schulz A, Bonaventura K, Fengler A

free

10.4244/EIJV9I5A98 • Sep 27, 2013

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial

Waksman R, Serra A, Loh J, Malik F, Torguson R, Stahnke S, Von Strandmann R, Rodríguez A

free

10.4244/EIJV9I5A99 • Sep 27, 2013

Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?

Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Borger MA, Degenhardt R, Scheller B

free

10.4244/EIJV9I5A100 • Sep 27, 2013

Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale

Freixa X, Ibrahim R, Chan J, Garceau P, Dore A, Marcotte F, Mercier L-A, Pierre-Mongeon F, Basmadjian A, Khairy P, Asgar A

free